Balo Andrew K
SEC CIK 1323190 · EDGAR
Most active insiders at GCTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Balo Andrew K made no open-market trades at GCTK in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-07 | 2025-03-25+ | GCTK | Glucotrack, Inc. | Balo Andrew K | Dir | A - Grant | $0.00 | +4,692 | 75 | New | $0 |
| 2025-03-28 | 2025-03-26 | GCTK | Glucotrack, Inc. | Balo Andrew K | Dir | A - Grant | $0.00 | +4,490 | 4,490 | New | $0 | |
| M | 2023-03-14 | 2023-03-10 | DXCM | Dexcom | Balo Andrew K | EVP Regulatory Strategy Clinic | D - Sale to Iss | $111.40 | -11.7K | 59.3K | -16% | -$1.30M |
| M | 2022-03-10 | 2022-03-09 | DXCM | Dexcom | Balo Andrew K | EVP, Gbl Medical Affairs | D - Sale to Iss | $406.06 | -3,430 | 16.6K | -17% | -$1.39M |
| 2022-03-10 | 2022-03-08 | DXCM | Dexcom | Balo Andrew K | EVP, Gbl Medical Affairs | A - Grant | $0.00 | +4,984 | 19.0K | +35% | $0 | |
| MI | 2021-09-13 | 2021-09-09 | DXCM | Dexcom | Balo Andrew K | * | S - Sale | $546.78 | -5,597 | 11.9K | -32% | -$3.06M |
| I | 2021-09-13 | 2021-09-09 | DXCM | Dexcom | Balo Andrew K | * | J - Other | $0.00 | +2,498 | 13.2K | +23% | $0 |
| 2021-09-13 | 2021-09-09 | DXCM | Dexcom | Balo Andrew K | * | J - Other | $0.00 | -2,498 | 14.1K | -15% | $0 | |
| MI | 2021-08-04 | 2021-08-03 | DXCM | Dexcom | Balo Andrew K | * | S - Sale | $515.87 | -2,757 | 11.9K | -19% | -$1.42M |
| MI | 2021-07-08 | 2021-07-06 | DXCM | Dexcom | Balo Andrew K | * | S - Sale | $430.14 | -2,974 | 15.4K | -16% | -$1.28M |
Purchase Sale Sale after option exercise All abbreviations